EPIXOTIC HEMORRHAGE DISEASE (EHD), SOMETIMES REFERRED TO AS BLUE TONGUE, IS AN ACUTE INFECTIOUS AND OFTEN FATAL VIRAL DISEASE AFFECTING WILD RUMINANTS (DEER), INCLUDING WHITETAIL DEER. DEER BREEDERS CORPORATION IS ENGAGED IN ACQUIRING EHD ISOLATES FROM TISSUE SAMPLES USED BY VACCINE MANUFACTURERS TO DEVELOP AND EVOLVE VACCINES TO STAY IN FRONT OF THESE INFECTIOUS DISEASES. DBC IS ALSO ENGAGED IN THE DISTRIBUTIONS OF THESE VACCINES IN AN EFFORT TO CONTROL THESE INFECTIOUS DISEASES AMONGST THE POPULATION OF WILD RUMINANTS. DBC IS ENGAGED IN INTERFACING WITH THE TEXAS DEPARTMENT OF PARKS AND WILDLIFE AND OWNERS ON TRAP TRANSPORT AND TRANSPLANT OF WILDLIFE, SPECIFICALLY WHITETAIL DEER, WHICH INVOLVED THE ACQUISITION OF PERMITS TO ENGAGE IN SUCH ACTIVITIES AND ENSURING APPROPRIATE HABITAT EXISTS AND SUCH EFFORTS ARE COORDINATED ETHICALLY. DBC FUNDS GRANTS TO ACADEMIC INSTITUTIONS TO FUND STUDIES FOR DEVELOPING VACCINES FOR INFECTIOUS DISEASES.
Reported officers (all unpaid)
No paid executives reported in 2024. THE DEER BREEDERS CORPORATION reported 7 unpaid officers and board members on its 990.
Revenue and expenses over time
THE DEER BREEDERS CORPORATION reported revenue and expenses across 2 filing years.
Common questions about THE DEER BREEDERS CORPORATION
What are THE DEER BREEDERS CORPORATION's revenue and expenses?
In 2024, THE DEER BREEDERS CORPORATION reported $51k in total revenue and $335k in total expenses on its IRS Form 990.
Compare any role, sector, or revenue band
Build your own benchmark from millions of reported positions.